Because EBIT is a fund, sell-side analysts do not publish a direct price target on its shares. Instead, financial data providers build an implied objective by aggregating the 12-month price targets of the stocks the ETF actually holds. According to TipRanks, the average of analyst targets across the roughly 600 underlying companies translates to an implied objective of about $43.50 per unit, with a high around $49.07 and a low near $39.33. This is a calculated, holdings-weighted figure, not a promise, and it inherits the 12-month research horizon of the underlying analyst targets. It should be read as a barometer of how Wall Street views the fund's portfolio, rather than a dedicated forecast for the ETF's market price. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the industry.
EBIT has been trading in the $38 to $39 range in recent sessions, having pulled back from a 52-week high near $40.99. Reaching $43.50 from approximately $38.36 requires an advance of roughly 13%, a modest move by equity-market standards but one that would still require the fund to break decisively above its prior peak. The Harbor AlphaEdge Small Cap Earners ETF tracks an index of profitable U.S. small-cap companies — "small cap earners" — selected and weighted by profitability. The fund is heavily tilted toward financial services (about 26% of assets), followed by consumer cyclical, industrials, and energy, with top holdings including Navient (NAVI), StoneX (SNEX), Jackson Financial (JXN), PennyMac (PFSI), and Bread Financial (BFH).
A rally in small-cap value equities — the fund's core style — would be the primary driver. The portfolio trades at a forward price-to-earnings (P/E) ratio around 10, well below the broad market and the typical small-cap category, leaving room for multiple expansion if sentiment improves. The fund's profitability screen, which favors companies generating consistent earnings, provides a quality tilt that can outperform in choppy markets. Financials, the largest sector weight, tend to benefit from a steeper yield curve and steady-to-higher interest rates, supporting net interest margins for the banks and specialty lenders in the portfolio. Improving small-cap earnings momentum and any rotation away from mega-cap technology names into value-oriented segments would also support the implied objective. From what I see, the valuation discount stands out as a key factor here.
The principal obstacle is that the fund remains relatively small — assets under management (AUM) of roughly $12–13 million — with light trading volume, which can amplify price swings and widen bid-ask spreads. Its heavy financials and cyclical exposure makes it vulnerable to an economic slowdown, weakening credit conditions, or a rapid decline in interest rates, which would compress lenders' margins. A reversal in small-cap momentum, sector rotation back toward growth and large-cap technology, or a broader risk-off environment could also keep the fund below its prior high. Finally, the implied target is a backward-looking aggregation of analyst views on individual holdings, many of which carry their own wide target ranges and can lag actual market conditions.
On a technical basis, the 52-week high near $40.99 represents the key resistance level the fund must clear before the $43.50 objective becomes credible; that prior peak sits roughly 6–7% above recent prices. Support appears in the $37.50–$38 zone, near the 200-day moving average around $38 and the lower end of the recent trading range, with a more durable floor at the 52-week low near $31.92. The fund's long-term trend structure remains constructive — it is up roughly 14% year-to-date and more than 30% since its July 2024 inception — but it has been consolidating below its highs, a pattern that suggests the $41 area must first be reclaimed.
The implied $43.50 objective inherits a roughly 12-month research horizon from the underlying analyst targets, though individual targets on the holdings vary in timing and assumption. Key items to watch include Federal Reserve rate decisions and the shape of the yield curve, which directly affect the fund's financial holdings; quarterly small-cap earnings and guidance, which drive revisions to the underlying targets; and fund flows into small-cap value ETFs, which can signal shifting investor appetite. Changes in the ETF's holdings composition and any sustained break above or below the $41 resistance and $38 support zones are also worth tracking. I’m watching this closely for any shifts in rate expectations.
Tickeron's AI Daily Buy/Sell Signals have become a useful part of my routine for monitoring funds like this one. The platform applies artificial intelligence to track thousands of stocks and ETFs, delivering Buy, Sell, or Hold signals as conditions evolve. For something like EBIT that reacts quickly to small-cap and rate sentiment, these signals help spot momentum changes more efficiently than reviewing charts manually.
The $43.50 objective for the Harbor AlphaEdge Small Cap Earners ETF is an implied target derived from analyst price targets on the fund's underlying holdings, not a published consensus on the ETF itself. From a recent price near $38.36, reaching it would require a modest advance of about 13% and a breakout above the fund's 52-week high. Supportive factors include a discounted small-cap value valuation, a profitability-focused methodology, and meaningful financials exposure, while the main obstacles are the fund's small size, sector concentration, and sensitivity to rates and small-cap sentiment. The wide $39.33–$49.07 implied range underscores genuine uncertainty. No outcome is assured, and investors should weigh these factors against their own objectives before acting.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
The 10-day moving average for EBIT crossed bearishly below the 50-day moving average on November 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 5 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EBIT as a result. In 27 of 38 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.
The Moving Average Convergence Divergence Histogram (MACD) for EBIT turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 21 similar instances when the indicator turned negative. In 14 of the 21 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.
EBIT moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EBIT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
EBIT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 69 of 111 cases where EBIT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows